PillMemantine And Donepezil
Donepezil Hydrochloride + Memantine Hydrochloride
3 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | unknown | 8 | SUPPLYING |
| Macleods Pharmaceuticals Limited | unknown | 6 | SUPPLYING |
| AvKARE | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jun 15, 2026RESOLVEDShortage resolved: Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release (Amneal Pharmaceuticals)
Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release — reported in shortage by Amneal Pharmaceuticals. Therapeutic category: Neurology.
- Jun 15, 2026SHORTAGEDrug shortage: Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release (Amneal Pharmaceuticals)
Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release — reported in shortage by Amneal Pharmaceuticals. Therapeutic category: Neurology.